Smart Technology for Weight Loss and Metabolic Health
Not Applicable
Completed
- Conditions
- ObesityWeight LossOverweightPrediabetesLifestyle
- Registration Number
- NCT02742662
- Lead Sponsor
- Temple University
- Brief Summary
The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
- Overweight or obese BMI 25-42 kg/m2
- Employed in sedentary occupations
- Own a personal smartphone with unlimited data plan or >4 GigaByte data
- Proficient with use of smartphone applications and technology with current daily usage
- Ability to engage in moderate intensity exercise
- Weight stability for the last 2 months
- Participants must be willing to comply with all study-related procedures
Exclusion Criteria
- Current or planned pregnancy
- Cardiovascular, pulmonary, renal disease, joint disease
- Uncontrolled thyroid disease
- History of eating disorders, psychiatric disease
- History of substance abuse or dependence in the last 1 year
- Diabetes
- Shift work
- Previous weight loss surgery
- Use of weight loss drugs/diet/program in the last 6 weeks
- Inability to increase walking as a form of exercise and to engage in moderate intensity exercise
- Other conditions or medications that affect body weight/appetite/metabolism
- Serious or unstable medical or psychological conditions that would compromise the subject's safety for successful participation
- Incapable of adhering with an intensive lifestyle intervention using technology and smartphone applications
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in body weight in kg 6 months
- Secondary Outcome Measures
Name Time Method Change from baseline blood pressure 12 months Change from baseline waist circumference 12 months Change from baseline insulin resistance by homeostasis model assessment (HOMA-IR) 6 months Change from baseline hemoglobin A1c 6 months Change from baseline plasma triglycerides 6 months Change from baseline body weight in kg 12 months Change in Quality of Life 6 months after receiving the intervention SF36 Questionnaire in wait-listed control group after the intervention
Change in insulin resistance by homeostasis model assessment (HOMA-IR) 12 months compared to baseline and 6 months after receiving the intervention Wait-listed control group
Change in hemoglobin A1c 12 months compared to baseline and 6 months after receiving the intervention and from baseline Wait-listed control group
Change in plasma triglycerides 12 months compared to baseline and 6 months after receiving the intervention Wait-listed control group
Trial Locations
- Locations (1)
Temple University
🇺🇸Philadelphia, Pennsylvania, United States
Temple University🇺🇸Philadelphia, Pennsylvania, United States